XTL Biopharmaceuticals Ltd. logo

XTL Biopharmaceuticals Ltd. (XTLB)

Market Closed
27 Jun, 20:00
NASDAQ (CM) NASDAQ (CM)
$
1. 16
-0.02
-1.69%
$
10.22M Market Cap
- P/E Ratio
0% Div Yield
1,700 Volume
0 Eps
$ 1.18
Previous Close
Day Range
1.14 1.19
Year Range
0.86 3.05
Want to track XTLB and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

XTLB closed Friday lower at $1.16, a decrease of 1.69% from Thursday's close, completing a monthly decrease of -21.09% or $0.31. Over the past 12 months, XTLB stock lost -41.71%.
XTLB is not paying dividends to its shareholders.
The last earnings report, released on Jun 03, 2024, exceeded the consensus estimates by 0.09%. On average, the company has surpassed earnings expectations by 0.03%, based on the last three reports.
XTL Biopharmaceuticals Ltd. has completed 2 stock splits, with the recent split occurring on Feb 10, 2017.
The company's stock is traded on 5 different exchanges and in various currencies, with the primary listing on NASDAQ (CM) (USD).

XTLB Chart

Chart

Empty chart
The chart has 2 Y axes displaying values, and values.
Loading, please wait...
End of interactive chart.

XTL Biopharmaceuticals Ltd. Dividends

XTLB is not paying dividends to its shareholders.

XTL Biopharmaceuticals Ltd. Earnings

3 Jun 2024 Date
-
Cons. EPS
0.09
EPS
30 Apr 2024 Date
-
Cons. EPS
-
EPS
14 Mar 2024 Date
-
Cons. EPS
-
EPS
5 Dec 2023 Date
-
Cons. EPS
-
EPS
6 Dec 2016 Date
-
Cons. EPS
-
EPS
XTLB is not paying dividends to its shareholders.
3 Jun 2024 Date
-
Cons. EPS
0.09
EPS
30 Apr 2024 Date
-
Cons. EPS
-
EPS
14 Mar 2024 Date
-
Cons. EPS
-
EPS
5 Dec 2023 Date
-
Cons. EPS
-
EPS
6 Dec 2016 Date
-
Cons. EPS
-
EPS

XTL Biopharmaceuticals Ltd. (XTLB) FAQ

What is the stock price today?

The current price is $1.16.

On which exchange is it traded?

XTL Biopharmaceuticals Ltd. is listed on NASDAQ (CM).

What is its stock symbol?

The ticker symbol is XTLB.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0%.

What is its market cap?

As of today, the market cap is 10.22M.

Has XTL Biopharmaceuticals Ltd. ever had a stock split?

XTL Biopharmaceuticals Ltd. had 2 splits and the recent split was on Feb 10, 2017.

XTL Biopharmaceuticals Ltd. Profile

Biotechnology Industry
Healthcare Sector
Noam Band CEO
NASDAQ (CM) Exchange
98386D307 Cusip
IL Country
10 Employees
- Last Dividend
10 Feb 2017 Last Split
1 Sep 2005 IPO Date
XTL Biopharmaceuticals Ltd., a biopharmaceutical company, engages in the acquisition and development of pharmaceutical products for the treatment of autoimmune diseases. The company's lead drug candidate is hCDR1, a Phase II-ready asset for the treatment of systemic lupus erythematosus and Sjogren's syndrome. It has a licensing agreement with Yeda Research and Development Company Limited for the research, development, and commercialization of hCDR1 for various indications. The company was formerly known as Xenograft Technologies Ltd. and changed its name to XTL Biopharmaceuticals Ltd. in July 1995. XTL Biopharmaceuticals Ltd. was incorporated in 1993 and is headquartered in Ramat Gan, Israel.

Contact Information

Address: 5 Badner Street
Phone: 972 3 611 6600